Funding for this research was provided by:
Univerzita Karlova v Praze (UNCE MED 02, PROGES Q38)
EU operational programe (CZ.02.1.01/0.0/0.0/16_026/0008388)
Received: 9 June 2019
Accepted: 14 January 2020
First Online: 30 January 2020
Ethics approval and consent to participate
: The study was approved by the Multicenter ethics commettee of the University Hospital Kralovske Vinohrady, Prague, Czech Republic (Šrobárova 50, Prague, Czech Republic, email@example.com).
: Not applicable.
: Viktor Kočka received personal fees from Abbott Vascular, Medtronic and Terumo, Petr Toušek received personal fees from Medtronic. The authors declare that they have no competing interests.